Efficacy and Safety Study of SyB L-0501 for Patients With Chronic Lymphocytic Leukemia
Status:
Completed
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate safety and efficacy of SyB L-0501 after 2-day
intravenous infusion at a dose of 100 mg/m2/day to patients with chronic lymphocytic
leukemia.